ArticleCancers2024

Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.

Serena Janho Dit Hreich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.